Dihydrofolate Reductase 19-bp Deletion Polymorphism Modifies the Association of Folate Status with Memory in a Cross-sectional Multi-ethnic Study of Adults

Overview

Journal Am J Clin Nutr

Publisher Elsevier

Specialty Nutritional Sciences

Date 2015 Sep 11

PMID 26354538

Citations 13

Authors

Dana Philip

Assaf Buch

Denish Moorthy

Tammy M Scott

Laurence D Parnell

Chao-Qiang Lai

Jose M Ordovas

Jacob Selhub

Irwin H Rosenberg

Katherine L Tucker

Aron M Troen

Affiliations

Soon will be listed here.

Abstract

Background: Folate status has been positively associated with cognitive function in many studies; however, some studies have observed associations of poor cognitive outcomes with high folate. In search of an explanation, we hypothesized that the association of folate with cognition would be modified by the interaction of high-folate status with a common 19-bp deletion polymorphism in the dihydrofolate reductase (DHFR) gene. To our knowledge, the cognitive effects of this gene have not been studied previously.

Objective: We examined the association between cognitive outcomes with the 19-bp deletion DHFR polymorphism, folate status, and their interaction with high or normal plasma folate.

Design: This was a pooled cross-sectional study of the following 2 Boston-based cohorts of community living adults: the Boston Puerto Rican Health Study and the Nutrition, Aging, and Memory in Elders study. Individuals were genotyped for the DHFR 19-bp deletion genotype, and plasma folate status was determined. Cognitive outcomes included the Mini-Mental State Examination, Center for Epidemiologic Studies Depression Scale, and factor scores for the domains of memory, executive function, and attention from a set of cognitive tests.

Results: The prevalence of the homozygous deletion (del/del) genotype was 23%. In a multivariable analysis, high folate status (>17.8 ng/mL) was associated with better memory scores than was normal-folate status (fourth-fifth quintiles compared with first-third quintiles: β ± SE = -0.22 ± 0.06, P < 0.01). Carriers of the DHFR del/del genotype had worse memory scores (β ± SE = -0.24 ± 0.10, P < 0.05) and worse executive scores (β = -0.19, P < 0.05) than did those with the del/ins and ins/ins genotypes. Finally, we observed an interaction such that carriers of the del/del genotype with high folate had significantly worse memory scores than those of both noncarriers with high-folate and del/del carriers with normal-folate (β-interaction = 0.26 ± 0.13, P < 0.05).

Conclusions: This study identifies a putative gene-nutrient interaction that, if confirmed, would predict that a sizable minority carrying the del/del genotype might not benefit from high-folate status and could see a worsening of memory. An understanding of how genetic variation affects responses to high-folate exposure will help weigh risks and benefits of folate supplementation for individuals and public health.

Citing Articles

Interactions of SNPs in Folate Metabolism Related Genes on Prostate Cancer Aggressiveness in European Americans and African Americans.

Lin H, Steck S, Sarkar I, Fontham E, Diekman A, Rogers L Cancers (Basel). 2023; 15(6.

PMID: 36980585 PMC: 10046243. DOI: 10.3390/cancers15061699.

Profile of Folate in Breast Milk from Chinese Women over 1-400 Days Postpartum.

Su Y, Mao Y, Tian F, Cai X, Chen R, Li N Nutrients. 2022; 14(14).

PMID: 35889919 PMC: 9319857. DOI: 10.3390/nu14142962.

Overview of Neural Tube Defects: Gene-Environment Interactions, Preventative Approaches and Future Perspectives.

Isakovic J, Simunic I, Jagecic D, Hribljan V, Mitrecic D Biomedicines. 2022; 10(5).

PMID: 35625701 PMC: 9138472. DOI: 10.3390/biomedicines10050965.

Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer's Disease Datasets Reveals Genotype-Specific Changes Across Cell Types in Two Brain Regions.

Belonwu S, Li Y, Bunis D, Rao A, Warly Solsberg C, Oskotsky T Front Aging Neurosci. 2022; 14:749991.

PMID: 35572130 PMC: 9093608. DOI: 10.3389/fnagi.2022.749991.

The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials.

Wu Y, Smith A, Bastani N, Refsum H, Kwok T Hum Mol Genet. 2021; 31(7):1151-1158.

PMID: 34788822 PMC: 8976423. DOI: 10.1093/hmg/ddab246.

References

Brady C, Gaziano J, Cxypoliski R, Guarino P, Kaufman J, Warren S . Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis. 2009; 54(3):440-9. PMC: 2748786. DOI: 10.1053/j.ajkd.2009.05.013. View

Stanislawska-Sachadyn A, Brown K, Mitchell L, Woodside J, Young I, Scott J . An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women. Hum Genet. 2008; 123(3):289-95. DOI: 10.1007/s00439-008-0475-y. View

Clarke R, Bennett D, Parish S, Lewington S, Skeaff M, Eussen S . Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am J Clin Nutr. 2014; 100(2):657-66. PMC: 4095663. DOI: 10.3945/ajcn.113.076349. View

van der Linden I, Nguyen U, Heil S, Franke B, Vloet S, Gellekink H . Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol Genet Metab. 2007; 91(1):98-103. DOI: 10.1016/j.ymgme.2007.01.009. View

Tucker K, Qiao N, Scott T, Rosenberg I, Spiro 3rd A . High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005; 82(3):627-35. DOI: 10.1093/ajcn.82.3.627. View

Kim Y . Will mandatory folic acid fortification prevent or promote cancer?. Am J Clin Nutr. 2004; 80(5):1123-8. DOI: 10.1093/ajcn/80.5.1123. View

Banka S, Blom H, Walter J, Aziz M, Urquhart J, Clouthier C . Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet. 2011; 88(2):216-25. PMC: 3035707. DOI: 10.1016/j.ajhg.2011.01.004. View

Whitsett J, Rangel Filho A, Sethumadhavan S, Celinska J, Widlansky M, Vasquez-Vivar J . Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling. Free Radic Biol Med. 2013; 63:143-50. PMC: 3748942. DOI: 10.1016/j.freeradbiomed.2013.04.035. View

Morris M, Selhub J, Jacques P . Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study. J Am Geriatr Soc. 2012; 60(8):1457-64. PMC: 3419282. DOI: 10.1111/j.1532-5415.2012.04076.x. View

10.

Aisen P, Schneider L, Sano M, Diaz-Arrastia R, van Dyck C, Weiner M . High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008; 300(15):1774-83. PMC: 2684821. DOI: 10.1001/jama.300.15.1774. View

11.

Bell I, Edman J, Miller J, Hebben N, Linn R, Ray D . Relationship of normal serum vitamin B12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol. 1990; 3(2):98-105. DOI: 10.1177/089198879000300208. View

12.

Cario H, Smith D, Blom H, Blau N, Bode H, Holzmann K . Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am J Hum Genet. 2011; 88(2):226-31. PMC: 3035706. DOI: 10.1016/j.ajhg.2011.01.007. View

13.

Choi J, Yates Z, Veysey M, Heo Y, Lucock M . Contemporary issues surrounding folic Acid fortification initiatives. Prev Nutr Food Sci. 2015; 19(4):247-60. PMC: 4287316. DOI: 10.3746/pnf.2014.19.4.247. View

14.

Folstein M, ROBINS L, Helzer J . The Mini-Mental State Examination. Arch Gen Psychiatry. 1983; 40(7):812. DOI: 10.1001/archpsyc.1983.01790060110016. View

15.

McMahon J, Green T, Skeaff C, Knight R, Mann J, Williams S . A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006; 354(26):2764-72. DOI: 10.1056/NEJMoa054025. View

16.

Eroglu A, Egin Y, Cam R, Akar N . The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Ann Hematol. 2008; 88(1):73-6. DOI: 10.1007/s00277-008-0569-6. View

17.

Sun X, Chiu C, Liebson E, Crivello N, Wang L, Claunch J . Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele. Alzheimer Dis Assoc Disord. 2009; 23(3):238-44. PMC: 2919337. DOI: 10.1097/WAD.0b013e31819cb3ac. View

18.

Barua S, Kuizon S, Junaid M . Folic acid supplementation in pregnancy and implications in health and disease. J Biomed Sci. 2014; 21:77. PMC: 4237823. DOI: 10.1186/s12929-014-0077-z. View

19.

Nachum-Biala Y, Troen A . B-vitamins for neuroprotection: narrowing the evidence gap. Biofactors. 2012; 38(2):145-50. DOI: 10.1002/biof.1006. View

20.

Morris M, Jacques P, Rosenberg I, Selhub J . Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr. 2010; 91(6):1733-44. DOI: 10.3945/ajcn.2009.28671. View